221 related articles for article (PubMed ID: 7732029)
1. The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism.
Burgess TL; Fisher EF; Ross SL; Bready JV; Qian YX; Bayewitch LA; Cohen AM; Herrera CJ; Hu SS; Kramer TB
Proc Natl Acad Sci U S A; 1995 Apr; 92(9):4051-5. PubMed ID: 7732029
[TBL] [Abstract][Full Text] [Related]
2. Effects of antisense c-myb oligonucleotides on vascular smooth muscle cell proliferation and response to vessel wall injury.
Villa AE; Guzman LA; Poptic EJ; Labhasetwar V; D'Souza S; Farrell CL; Plow EF; Levy RJ; DiCorleto PE; Topol EJ
Circ Res; 1995 Apr; 76(4):505-13. PubMed ID: 7895327
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of smooth muscle cell proliferation and migration in vitro by antisense oligonucleotide to c-myb.
Pitsch RJ; Goodman GR; Minion DJ; Madura JA; Fox PL; Graham LM
J Vasc Surg; 1996 May; 23(5):783-91. PubMed ID: 8667499
[TBL] [Abstract][Full Text] [Related]
4. [Effects of an anti-c-myb antisense oligonucleotide on myo-intimal proliferation. Specificity of action and consequences on vasoreactivity].
Castier Y; Chemla E; Chardigny C; Nierat J; Eudes D; Vasseur MA; Bruneval P; Carpentier A; Fabiani JN
Arch Mal Coeur Vaiss; 1996 Jul; 89(7):889-96. PubMed ID: 8869251
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of c-myc expression by antisense oligonucleotides inhibits proliferation of human smooth muscle cells.
Shi Y; Hutchinson HG; Hall DJ; Zalewski A
Circulation; 1993 Sep; 88(3):1190-5. PubMed ID: 8353880
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides.
Bennett MR; Anglin S; McEwan JR; Jagoe R; Newby AC; Evan GI
J Clin Invest; 1994 Feb; 93(2):820-8. PubMed ID: 8113414
[TBL] [Abstract][Full Text] [Related]
7. Antisense nonmuscle myosin heavy chain and c-myb oligonucleotides suppress smooth muscle cell proliferation in vitro.
Simons M; Rosenberg RD
Circ Res; 1992 Apr; 70(4):835-43. PubMed ID: 1551207
[TBL] [Abstract][Full Text] [Related]
8. Contiguous four-guanosine sequence in c-myc antisense phosphorothioate oligonucleotides inhibits cell growth on human lung cancer cells: possible involvement of cell adhesion inhibition.
Saijo Y; Uchiyama B; Abe T; Satoh K; Nukiwa T
Jpn J Cancer Res; 1997 Jan; 88(1):26-33. PubMed ID: 9045892
[TBL] [Abstract][Full Text] [Related]
9. The activity of c-myb antisense oligonucleotide to prevent intimal hyperplasia is nonspecific.
Castier Y; Chemla E; Nierat J; Heudes D; Vasseur MA; Rajnoch C; Bruneval P; Carpentier A; Fabiani JN
J Cardiovasc Surg (Torino); 1998 Feb; 39(1):1-7. PubMed ID: 9537527
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of antisense oligodeoxynucleotides targeting c-myc mRNA on smooth muscle cell proliferation and migration.
Biro S; Fu YM; Yu ZX; Epstein SE
Proc Natl Acad Sci U S A; 1993 Jan; 90(2):654-8. PubMed ID: 8421701
[TBL] [Abstract][Full Text] [Related]
11. Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo.
Simons M; Edelman ER; DeKeyser JL; Langer R; Rosenberg RD
Nature; 1992 Sep; 359(6390):67-70. PubMed ID: 1522889
[TBL] [Abstract][Full Text] [Related]
12. Antiproliferative effects of a c-myc antisense oligonucleotide on human arterial smooth muscle cells.
Ebbecke M; Unterberg C; Buchwald A; Stöhr S; Wiegand V
Basic Res Cardiol; 1992; 87(6):585-91. PubMed ID: 1485890
[TBL] [Abstract][Full Text] [Related]
13. c-myc in vasculoproliferative disease.
Edelman ER; Simons M; Sirois MG; Rosenberg RD
Circ Res; 1995 Feb; 76(2):176-82. PubMed ID: 7834827
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of vascular smooth muscle cell proliferation by ribozymes that cleave c-myb mRNA.
Jarvis TC; Alby LJ; Beaudry AA; Wincott FE; Beigelman L; McSwiggen JA; Usman N; Stinchcomb DT
RNA; 1996 May; 2(5):419-28. PubMed ID: 8665409
[TBL] [Abstract][Full Text] [Related]
15. Expression of the c-myb proto-oncogene in bovine vascular smooth muscle cells.
Brown KE; Kindy MS; Sonenshein GE
J Biol Chem; 1992 Mar; 267(7):4625-30. PubMed ID: 1537845
[TBL] [Abstract][Full Text] [Related]
16. Sequence-specific antiproliferative effects of antisense and end-capping-modified antisense oligodeoxynucleotides targeted against the 5'-terminus of basic-fibroblast-growth-factor mRNA in coronary smooth muscle cells.
Schmidt A; Sindermann J; Peyman A; Uhlmann E; Will DW; Müller JG; Breithardt G; Buddecke E
Eur J Biochem; 1997 Sep; 248(2):543-9. PubMed ID: 9346314
[TBL] [Abstract][Full Text] [Related]
17. The proto-oncogene c-myb mediates an intracellular calcium rise during the late G1 phase of the cell cycle.
Simons M; Morgan KG; Parker C; Collins E; Rosenberg RD
J Biol Chem; 1993 Jan; 268(1):627-32. PubMed ID: 8416967
[TBL] [Abstract][Full Text] [Related]
18. Oligonucleotide N3'-->P5' phosphoramidates as antisense agents.
Gryaznov S; Skorski T; Cucco C; Nieborowska-Skorska M; Chiu CY; Lloyd D; Chen JK; Koziolkiewicz M; Calabretta B
Nucleic Acids Res; 1996 Apr; 24(8):1508-14. PubMed ID: 8628685
[TBL] [Abstract][Full Text] [Related]
19. [Antisense oligonucleotides inhibit c-myc and PCNA expression in the vascular smooth muscle cells].
Bian J; Zhang B; Chen S
Zhonghua Yi Xue Za Zhi; 1999 Jan; 79(1):10-4. PubMed ID: 11600998
[TBL] [Abstract][Full Text] [Related]
20. Localization of c-Myb and induction of apoptosis by antisense oligonucleotide c-Myb after angioplasty of porcine coronary arteries.
Lambert DL; Malik N; Shepherd L; Gunn J; Francis SE; King A; Crossman DC; Cumberland DC; Holt CM
Arterioscler Thromb Vasc Biol; 2001 Nov; 21(11):1727-32. PubMed ID: 11701457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
